Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSleep disturbances are not listed among Wegovy's most common side effects, yet many people starting semaglutide notice their nights feel different in the early weeks. The link between Wegovy, sleep side effects, and the GI symptoms that can disrupt rest is worth understanding clearly before you begin. Wegovy (semaglutide) is a prescription-only medicine for weight management; a prescriber assesses whether it is clinically suitable for you before any treatment is supplied. You can read the full side-effect profile in NHS guidance on semaglutide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most widespread worry on this topic is that semaglutide directly interferes with sleep architecture, altering REM cycles or triggering insomnia through some hormonal mechanism. The clinical evidence does not support that framing. In the STEP 1 trial, the main large-scale phase 3 study of semaglutide 2.4mg for weight management, primary adverse events were gastrointestinal: nausea affected around 44% of participants, vomiting around 24%, diarrhoea around 30%. Direct sleep disorders were not among the commonly reported outcomes. The NHS semaglutide medicines page lists nausea, diarrhoea, constipation, vomiting, headache, dizziness and fatigue as the effects most people encounter, sleep disruption as a standalone category is not in that list.
That does not mean your sleep is guaranteed to be unaffected. What the evidence does show is that the route to disrupted nights is almost always indirect: GI discomfort makes lying down uncomfortable, nausea peaks or lingers after an evening meal, or fatigue during the day shifts the rhythm of when you feel ready for sleep. That distinction matters, because managing GI timing (when you eat, how much, how close to bedtime) is something a prescriber or dietitian can help with, whereas a direct pharmacological sleep effect would need a different kind of assessment altogether.
If you are exploring the full range of Wegovy side effects before starting treatment, the GI picture deserves the most attention, because it shapes most of what people experience in the early phase.
Fatigue is a recognised side effect of semaglutide, and it is worth understanding how it interacts with sleep rather than assuming the two are the same thing. Some people on Wegovy feel genuinely tired (particularly in the first few weeks or after stepping up to a higher dose) and that tiredness can either improve sleep (falling asleep more readily) or work against it (feeling wired-tired, waking early, or napping in the afternoon in a way that disrupts the night). Our clinical team addresses this distinction in more detail on the fatigue and sleepiness page.
Nausea that peaks in the evening is the other common disruptor. Lying flat when the stomach is unsettled is uncomfortable for most people, and some find they wake in the night feeling queasy even if the initial dose of nausea had eased during the day. Practical adjustments (keeping meals light and earlier in the evening, staying upright for a couple of hours after eating, keeping a glass of water on the bedside table) can reduce the overnight impact. If you are on the starting dose and want to know what to expect, our guide to the 0.5mg dose side effects covers what most people notice at that early stage, including how nausea typically behaves before the body adjusts. The weekly injection timing also matters: some people find that injecting on a weekend morning means peak-intensity nausea falls during the day rather than overnight, though this is something to discuss with your prescriber rather than change independently.
Constipation, which affects a meaningful proportion of people on Wegovy, can also disturb sleep when abdominal discomfort is persistent. Hydration and fibre adequacy are relevant here, and both are areas where your prescriber and the NHS Better Health guidance on diet alongside weight-loss treatment can provide practical direction.
Most sleep disruption in the early weeks of Wegovy resolves as the body adjusts and GI side effects settle. That said, there are situations where symptoms warrant prompt medical attention rather than a wait-and-see approach. Severe stomach pain (particularly pain that is persistent and radiates toward the back, with or without vomiting) should not be managed overnight with over-the-counter remedies. In January 2026 the MHRA issued a Drug Safety Update reminding patients and prescribers that acute pancreatitis, while infrequent, is a known serious side effect of GLP-1 medicines; the hallmark symptom is exactly that pattern of pain. Contact a GP or NHS 111 rather than waiting until morning if that presentation occurs.
Equally, severe dehydration from prolonged vomiting or diarrhoea (which can cause dizziness, palpitations, and poor sleep) needs medical input. Signs of an allergic reaction (facial swelling, difficulty breathing, widespread rash) are a 999 situation regardless of the time of day. If you notice persistent low mood or thoughts of self-harm at any point during treatment, contact your prescriber or GP promptly; this is listed in the product information as a side effect to monitor.
For side effects that are uncomfortable but not urgent, the side-effects management page covers practical steps, and you can always reach the nume aftercare team directly through our contact page. Suspected side effects (including unusual sleep patterns you think are medicine-related) can be reported to the MHRA via the Yellow Card scheme; patient reports contribute to the UK's post-market safety monitoring and are genuinely valuable.
If you already have a sleep condition (obstructive sleep apnoea in particular) it is worth raising this at consultation, not because semaglutide is contraindicated, but because weight loss can meaningfully improve sleep apnoea over time and your prescriber will want to understand the baseline. If you are still weighing up whether this treatment is right for you, our Wegovy treatment page explains how the medicine works, who it is suitable for, and what supervised treatment involves. Full eligibility is assessed individually during the consultation, not by BMI alone.
People who experience few or no side effects on Wegovy do exist, it is not universal that the early weeks feel rough. Those who do find the transition harder often report that knowing what to expect, and having a prescriber to contact, made the difference. That is the practical value of a properly supervised private route to treatment, and you can read more about how we work on the about us page.
Our prescribers discuss side effects (including sleep-related concerns) as part of every consultation. If you're ready to talk through suitability, check your eligibility to start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.